Brussels, 02/08/2011 (Agence Europe) - On Tuesday 2 August, the European Commission gave clearance for the acquisition of pharmaceutical company Nycomed of Switzerland by Takeda of Japan, a global group (medicines, medical equipment, chemical products). Both companies supply pump inhibitors (PPIs), a type of drug used to treat a range of common disorders related to acid secretion by the stomach. Review of the transaction, notified on 26 June, has shown that the combined market share of...